The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...
GlobalData on MSN2d
AliveDx gains IVDR CE mark for MosaiQ AiPlex CTDplus assayAliveDx’s CE mark for the systematic autoimmune rheumatic disease (SARD) assay marks its fifth approval in the past 18 months ...
The following is a summary of “NTHi killing activity is reduced in COPD patients and is associated with a differential ...
Acrivon Therapeutics, Inc. (ACRV) is up by 14 percent on Wednesday. The stock surged after the company announced that the U.S. Food ...
Roche has received 510(k) clearance with a Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver from the US Food ...
The prevalence and prognostic significance of KRAS G12C mutation in metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract ...
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15–49 years old ...
The test, which runs on the Swiss company's high-throughput MosaiQ System, detects 15 different autoantibodies.
Tests broaden access to accurate, easy-to-use diagnostics for patients in a decentralised setting Roche has been granted US ...
Boster Biological Technology advances biotechnology research with its cutting-edge multiplex ELISA service, delivering precision solutions in cytokine assays, custom monoclonal antibodies, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback